NEW YORK (GenomeWeb) – Fluidigm said after the close of the market on Tuesday that its revenue for the fourth quarter of 2014 is expected to be approximately $33.4 million.

On average, analysts were expecting Q4 revenues of $33.3 million for the South San Francisco, Calif.-based life science analytical and preparatory systems firm.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York Times and ProPublica say that many physicians fail to disclose their financial ties when publishing in medical journals.

The Wall Street Journal reports Human Longevity's valuation has dropped by 80 percent.

Science reports that the US National Cancer Institute is cutting its operating budget by 5 percent.

In PLOS this week: similar variants seen in bullbogs, people with Robinow syndrome; ApoE genotypes in African-American, Puerto Rican populations; and more.